A. de Boer

First name
A.
Last name
de Boer
Ahmadizar, F., Souverein, P., de Boer, A., & van der Zee, A. H. M. -. (2018). Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13482
View
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2018). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
View
Oshagbemi, O. A., Keene, S. J., Driessen, J. H. M., Jordan, R., Wouters, E. F. M., de Boer, A., et al. (2018). Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respir Med. http://doi.org/10.1016/j.rmed.2018.09.010
View
Mahmoudpour, S. H., Asselbergs, F. W., Souverein, P. C., de Boer, A., & van der Zee, A. H. M. -. (2018). Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13692
View
Tran-Duy, A., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., et al. (2019). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
View
Lefeber, G. J., Koek, H. L., Souverein, P. C., Bouvy, M. L., de Boer, A., & Knol, W. (2019). Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database. J Am Geriatr Soc. http://doi.org/10.1111/jgs.16227
View
Gieling, E., de Vries, F., Williams, R., van Onzenoort, H. A. W., de Boer, A., Cate, T., et al. (2019). Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists. Int J Clin Pharm. http://doi.org/10.1007/s11096-019-00916-1
View
Oshagbemi, O. A., Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. M. -, Driessen, J. H. M., de Boer, A., & de Vries, F. (2019). C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD. Pulm Pharmacol Ther. http://doi.org/10.1016/j.pupt.2019.101870
View
Zhang, Y., Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., van der Zee, A. H. M. -, & de Boer, A. (2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14227
View
Althunian, T. A., de Boer, A., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel, O. H. (2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5065
View